YAP1 and neoplasm: After tumorigenesis, due to reduced fluid flow [81], circulating tumor cells (CTCs) have increased lymphatic system retention, which may activate YES-related protein 1 (YAP1) and transcriptional coactivators with PDZ-binding motif (TAZ) signaling pathways in CTCs.